← Open Payments lookup

BRENDA KOBUSINGYE: Open Payments

NPI 1407556038 · WALTHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,295 in 21 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $413 · 2025 $1,295

Food & beverage: $1,295
CompanyPaymentsAmount
ABBVIE INC.3$257
Neurocrine BioSciences, Inc.7$250
Otsuka America Pharmaceutical, Inc.3$218
E.R. Squibb & Sons, L.L.C.2$154
Gilead Sciences, Inc.1$135
Biogen, Inc.1$114
Alkermes, Inc.1$95
Teva Pharmaceuticals USA, Inc.2$48
Vanda Pharmaceuticals Inc.1$23

Products named: VRAYLAR, INGREZZA, COBENFY, Epclusa, ZURZUVAE, ABILIFY MAINTENA, REXULTI, LYBALVI.

Industry payments across MA — which companies pay providers there.